Working with a healthcare provider who understands your unique needs and can monitor your progress is key to achieving long-term, sustainable weight loss
Patients with obesity and diabetes who were not on GLP-1 receptor agonists also had residual gastric contents at an alarmingly high rate
We refer readers to that section for general comments related to the Emergency Care Access & Timeliness eCQM
Cagrilintide side effects are most often digestive symptoms, especially nausea, vomiting, diarrhea, constipation, reduced appetite, and stomach discomfort
Some GLP-1 drugs are also used for obesity treatment because they help reduce appetite, slow gastric emptying, and support weight loss
At the same time, collagen stimulation and regenerative activity initiated by it may continue long after administration